Canada is seeking offers for the supply of Trivalent Annual Influenza Vaccine, duly authorized for sale in Canada. The period of the contract is from award to March 31, 2026.
AI Analysis
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.
Basic information
Reference
WS5019923196-Doc5022250612
Solicitation no.
WS5019923196
Buyer
Department of Public Works and Government Services (PSPC)
UNSPSC 51000000 — Drugs and Pharmaceutical Products
Delivery & regions
Province
Quebec
Regions of delivery
*Nunavut Territory
*Yukon
*Newfoundland and Labrador
*Prince Edward Island
*National Capital Region (NCR)
*Northwest Territories
*Alberta
*Ontario (except NCR)
*British Columbia
*Manitoba
*Saskatchewan
*Quebec (except NCR)
*New Brunswick
*Nova Scotia
Contract term
April 1, 2025 → ?
Key dates
Published
February 14, 2025
Closes
March 5, 2025
Amendment no.
001
Contact
End-user
Department of Public Works and Government Services (PSPC)
Suppliers who have won similar work from this buyer before.
1
BOEHRINGER INGELHEIM ANIMAL HEALTH
2 contracts won· latest May 28, 2025
CAD $36.2M
total awarded
2
Moderna Biopharma Canada Corporation
1 contract won· latest June 30, 2025
CAD $360.5M
total awarded
3
Pfizer Canada ULC
1 contract won· latest January 25, 2023
CAD $39.5M
total awarded
4
SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE
1 contract won· latest March 30, 2026
CAD $37.8M
total awarded
5
Emergent Product Development Gaithersburg Inc
1 contract won· latest February 25, 2026
CAD $34.2M
total awarded
BOEHRINGER INGELHEIM ANIMAL HEALTH is the most likely incumbent, based on how often and how recently they have won this buyer’s work in this category. To displace them, expect to need a clearly stronger proposition or price.
